| #1 | | | Istanbul, Turkey | | 21+ years | Tumor Marker Blood Test, CT (computer tomography) | — | — | International Organization for Standardization, Joint Commission International |
| #2 | | | Istanbul, Turkey | | 12+ years | CAR T-cell therapy, Elranatamab chemotherapy | Refractory multiple myeloma | Offers CAR T-cell therapy with a 28-day hospitalization protocol. Prof. Sevindik specializes in hematologic malignancies and has published on refractory cases. JCI-accredited facility with dedicated hematology department. | Joint Commission International , International Organization for Standardization |
| #3 | | | Istanbul, Turkey | | 26+ years | CAR T-cell therapy | Advanced or relapsed blood cancers | JCI-accredited facility with dedicated hematologists experienced in complex blood cancer cases. Over 900 CAR T-cell therapy procedures performed by the hematology team. | International Organization for Standardization, Joint Commission International |
| #4 | | | Istanbul, Turkey | | 33+ years | CAR T-cell therapy, autologous stem cell transplantation | Multiple myeloma patients | JCI-accredited hematology department with specialized CAR T-cell therapy. Doctor has performed 900+ treatments and prepares personalized plans. Includes remission monitoring with PET-CT and bone marrow analysis. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) |
| #5 | | | Istanbul, Turkey | | 27+ years | CAR T-cell therapy, autologous stem cell transplantation, bone marrow aspiration/biopsy, PET/CT response evaluation | Patients with resistant diffuse large B-cell lymphoma | Specializes in advanced lymphoma treatments with diagnostic packages to assess therapy options. Offers a 32,500 USD autologous stem cell transplant package if CAR T-cell therapy is not accessible. 91% patient recommendation rate. | International Organization for Standardization, Joint Commission International |
| #6 | | | Istanbul, Turkey | | 14+ years | CAR T-cell therapy, autologous transplant | Refractory non-Hodgkin's lymphoma | Specializes in hard-to-treat cases with CAR T-cell therapy and autologous transplants. JCI accredited with a dedicated adult and pediatric bone marrow transplantation center. | Joint Commission International , Patient choice in Pediatric Oncology & Hematology Oncology |
| #7 | | | Istanbul, Turkey | | 33+ years | CT scan of the body part, MRI of one area | — | — | International Organization for Standardization, Joint Commission International |
| #8 | | | Istanbul, Turkey | | 34+ years | Allogeneic bone marrow transplantation, haploidentical bone marrow transplantation, robotic chemotherapy preparation | Pediatric and adult blood cancers | Largest pediatric and adult Bone Marrow Transplantation Unit in the region with 45 beds. Specializes in high-risk cases and offers HEPA-filtered rooms for safety. | The Baby-friendly Hospital Initiative (BFHI) by WHO and UNICEF, Turkish Medical Association |
| #9 | | | Ankara, Turkey | | 16+ years | CAR T-cell therapy | — | — | Turkish Medical Association, Joint Commission International |
| #10 | | | Istanbul, Turkey | | 33+ years | CAR T-cell therapy, Complete blood count | — | — | International Organization for Standardization, Joint Commission International |